Compare Enbridge Inc (ENB) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enbridge Inc vs Oscar Health Inc — how do they compare? Enbridge Inc trades at $56.35 (market cap $121.39B), while Oscar Health Inc trades at $30.14 (market cap $9.23B). The key difference: Enbridge Inc is far larger — about 13.2× Oscar Health Inc's market cap, and Enbridge Inc pays a 5.01% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals.
| ENB | OSCR | |
|---|---|---|
Market Cap | $121.39B | $9.23B |
Sector | Energy | Health |
52-Week High | $58.04 | $32.18 |
52-Week Low | $44.59 | $10.85 |
Enterprise Value | $202.19B | $4.85B |
Dividend Yield | 5.01% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enbridge (ENB) trades at $55.89, up 1.49% recently, with technical indicators showing a bullish trend. The company reported strong Q1 2026 earnings, beating estimates with $0.71 EPS, and maintains a robust dividend. Revenue grew to $65.19B in 2025, with net income of $7.49B, though valuation ratios like a P/E of 27.02 appear elevated relative to historical norms. Analyst sentiment is mixed with a 48% buy rating, while recent news highlights the company's $28B growth project pipeline and its positioning as a defensive, high-yield stock amid market volatility.
The outlook for ENB is balanced: growth projects and consistent cash flow support dividend sustainability, offering a defensive yield in uncertain markets. However, risks include high leverage, sensitivity to interest rates, and execution challenges on capital projects. The stock's current valuation may limit near-term upside, making it more suitable for income-focused investors rather than those seeking rapid growth.
Oscar Health (OSCR) trades at $30.73, down 1.09% on the day, with a bullish technical outlook supported by moving averages. The stock shows strong revenue growth, with 2026 revenue projected at $13.3 billion, but remains unprofitable with a net margin of -0.3%. Recent news highlights its momentum, including a 102.8% year-to-date gain and positive coverage from The Motley Fool and Zacks.
The outlook is mixed: strong revenue growth and bullish technicals offer upside potential, but profitability challenges and a consensus price target below the current price signal caution. Key risks include execution in a competitive insurance market and sustained losses. Analyst sentiment is divided, with a hold-heavy consensus.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enbridge Inc
Enbridge owns extensive midstream assets that transport hydrocarbons across the U.S. and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. Finally, the firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.
Read more on ENB →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
